Artwork

Konten disediakan oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

Episode 28. Management of CCUS

47:54
 
Bagikan
 

Manage episode 374605215 series 3369804
Konten disediakan oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

In this episode, we discuss the diagnosis and management/monitoring of Clonal Cytopenias of Unknown Significance (CCUS) with Dr. Uma Borate. We also discuss the emerging data on risk stratification and key trials in this space that are currently ongoing. Here are the shownotes:

1. CCUS and risk of transformation to myeloid neoplasms:
https://www.sciencedirect.com/science/article/pii/S0006497121013471

2. Prediction of risk for myeloid neoplasms in clonal hematopoiesis:

https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200310

3. CHRS risk score:

http://www.chrsapp.com

4. Germline predisposition to clonal hematopoiesis:

https://www.sciencedirect.com/science/article/abs/pii/S0145212623006094?via%3Dihub

https://www.nature.com/articles/s41586-020-2819-2

5. Cancer therapy shapes the fitness landscape of clonal hematopoiesis:

https://www.nature.com/articles/s41588-020-00710-0

6. Canakinumab for the prevention of progression to cancer in patients with Clonal Cytopenias of Unknown Significance, IMPACT Study:

https://clinicaltrials.gov/study/NCT05641831?cond=CCUS%20Clonal%20Cytopenia%20of%20Undetermined%20Significance&rank=3

7. Ivosidenib in patients with CCUS and mutations in IDH1:

https://classic.clinicaltrials.gov/ct2/show/NCT05030441

https://sites.wustl.edu/pimm/

  continue reading

57 episode

Artwork
iconBagikan
 
Manage episode 374605215 series 3369804
Konten disediakan oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

In this episode, we discuss the diagnosis and management/monitoring of Clonal Cytopenias of Unknown Significance (CCUS) with Dr. Uma Borate. We also discuss the emerging data on risk stratification and key trials in this space that are currently ongoing. Here are the shownotes:

1. CCUS and risk of transformation to myeloid neoplasms:
https://www.sciencedirect.com/science/article/pii/S0006497121013471

2. Prediction of risk for myeloid neoplasms in clonal hematopoiesis:

https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200310

3. CHRS risk score:

http://www.chrsapp.com

4. Germline predisposition to clonal hematopoiesis:

https://www.sciencedirect.com/science/article/abs/pii/S0145212623006094?via%3Dihub

https://www.nature.com/articles/s41586-020-2819-2

5. Cancer therapy shapes the fitness landscape of clonal hematopoiesis:

https://www.nature.com/articles/s41588-020-00710-0

6. Canakinumab for the prevention of progression to cancer in patients with Clonal Cytopenias of Unknown Significance, IMPACT Study:

https://clinicaltrials.gov/study/NCT05641831?cond=CCUS%20Clonal%20Cytopenia%20of%20Undetermined%20Significance&rank=3

7. Ivosidenib in patients with CCUS and mutations in IDH1:

https://classic.clinicaltrials.gov/ct2/show/NCT05030441

https://sites.wustl.edu/pimm/

  continue reading

57 episode

כל הפרקים

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat

Dengarkan acara ini sambil menjelajah
Putar